{
    "title": "Shionogi shares plunge on concerns over COVID pill risk to pregnancies",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10713817/Shionogi-shares-plunge-15-pregnancy-risk-concern-COVID-pill.html",
    "date": "2022-04-13",
    "keywords": [
        "birth",
        "drug",
        "treatment",
        "approval",
        "company",
        "shionogi",
        "amp",
        "wednesday",
        "use",
        "pill",
        "safety",
        "government",
        "coronavirus",
        "merck",
        "tokyo",
        "april",
        "co",
        "trading",
        "covid19",
        "pregnancy",
        "link",
        "spokesperson",
        "review",
        "data",
        "news",
        "report",
        "source",
        "statement",
        "market",
        "application",
        "feb",
        "month",
        "agreement",
        "protease",
        "inhibitor",
        "s217622",
        "pfizer",
        "inc",
        "phase",
        "trial",
        "worldwide",
        "support",
        "chief",
        "executive",
        "isao",
        "teshirogi",
        "production",
        "year",
        "analyst",
        "stephen",
        "barker",
        "buy",
        "note",
        "defect",
        "success",
        "covid",
        "demand",
        "molnupiravir",
        "ridgeback",
        "code",
        "control",
        "swift",
        "simon",
        "cameronmoore",
        "donovan"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}